Value2021202220232024TTMSelling/general/admin expenses45.76 M58.53 M58.95 M56.57 M45.65 MResearch & development29.12 M45.8 M53.02 M50.59 M46.75 MOperating income71.47 M97.23 M103.46 M100.1 M84.09 MNon-Operating Income, Total304 K4.27 M17.19 M13.6 M5.02 MInterest expense, net of interest capitalized22 K011.55 M3.05 M1.96 MNon-Operating Income, excl. Interest Expenses282 K4.6 M6.22 M10.96 M3.96 MUnusual income/expense0-333 K-578 K-417 K-898 KPretax income70.58 M100.67 M109.1 M86.5 M79.08 MEquity in earnings———2.65 M6.62 MTaxes00098 K271 KNon-controlling/minority interest—————After tax other income/expense0————Net income before discontinued operations71.17 M92.97 M86.28 M86.6 M79.35 MDiscontinued operations—————Net income71.17 M92.97 M86.28 M86.6 M79.35 MDilution adjustment—————Preferred dividends—————Diluted net income available to common stockholders71.17 M92.97 M86.28 M86.6 M79.35 MBasic earnings per share (Basic EPS)-1.17-1.49-1.35-1.39-1.36Diluted earnings per share (Diluted EPS)-1.17-1.49-1.35-1.39-1.36Average basic shares outstanding60.86 M62.43 M63.85 M62.35 M238.43 MDiluted shares outstanding60.86 M62.43 M63.85 M62.35 M238.43 MEBITDA-65.12 M-88.56 M-80.74 M-84.67 M-69.73 MEBIT-71.47 M-97.23 M-103.46 M-100.1 M-84.09 MCost of revenue3.21 M8.4 M8.15 M7.12 M8.07 MOther cost of goods sold—507 K872 K179 K139 KDepreciation & amortization (cash flow)6.36 M8.68 M22.73 M15.43 M14.37 M
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.